Mauricio Lisker‐Melman
- Hepatology top 0.2%
- Hepatitis C virus research 48
- Liver Disease and Transplantation 10
- Hepatitis Viruses Studies and Epidemiology 9
- Epidemiology top 1%
- Hepatitis B Virus Studies 45
- Liver Disease Diagnosis and Treatment 43
- Transplantation top 5%
- Rheumatology top 2%
- Infectious Diseases top 5%
-
- Alcohol Consumption and Health Effects 5
-
- Diet, Metabolism, and Disease 4
-
- Organ Transplantation Techniques and Outcomes 4
- Co-authors
- Jay H. HoofnagleAdrian M. Di BisceglieChris KassianidesLinda MurrayJeanne G. WaggonerZachary GoodmanSteven M. BanksPaul Martin
- Journals
- New England Journal of Medicine (1 paper)SHILAP Revista de lepidopterología (1 paper)Annals of Internal Medicine (1 paper)
- Partner nations
- United StatesCanadaMexico
In The Last Decade
Mauricio Lisker‐Melman
76 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 2.3k
- Epidemiology 2.0k
- Transplantation 92
- Rheumatology 378
- Infectious Diseases 248
Countries citing papers authored by Mauricio Lisker‐Melman
This map shows the geographic impact of Mauricio Lisker‐Melman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauricio Lisker‐Melman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauricio Lisker‐Melman more than expected).
Fields of papers citing papers by Mauricio Lisker‐Melman
This network shows the impact of papers produced by Mauricio Lisker‐Melman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauricio Lisker‐Melman. The network helps show where Mauricio Lisker‐Melman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mauricio Lisker‐Melman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 11 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 12 | |
| 8 | 2020 | 49 | |
| 9 | 2019 | 16 | |
| 10 | 2015 | 5 | |
| 11 | 2014 | 16 | |
| 12 | 2012 | 2 | |
| 13 | 2011 | 12 | |
| 14 | 2008 | 12 | |
| 15 | 2008 | 14 | |
| 16 | 2006 | 14 | |
| 17 | 2004 | 76 | |
| 18 | 2003 | 5 | |
| 19 | 1990 | 26 | |
| 20 | Recombinant Interferon Alfa Therapy for Chronic Hepatitis Cbreakdown → | 1989 | 1054 |
About Mauricio Lisker‐Melman
Mauricio Lisker‐Melman is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 79 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (48 papers), Hepatitis B Virus Studies (45 papers), Liver Disease Diagnosis and Treatment (43 papers), Liver Disease and Transplantation (10 papers), Hepatitis Viruses Studies and Epidemiology (9 papers), Alcohol Consumption and Health Effects (5 papers), Diet, Metabolism, and Disease (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). The work is most often cited by research in Hepatology (2.3k citations), Epidemiology (2.0k citations) and Transplantation (92 citations). Mauricio Lisker‐Melman has collaborated with scholars based in United States, Canada and Mexico. Frequent co-authors include Jay H. Hoofnagle, Adrian M. Di Bisceglie, Chris Kassianides, Linda Murray, Jeanne G. Waggoner, Zachary Goodman, Steven M. Banks, Paul Martin, Jeffrey S. Crippin and Paul Martin. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.